Skip to main content
Abbott8-K: Acquisition announced

Abbott raises $20B in debt to fund the acquisition of Exact Sciences Corporation.

What happened

Abbott is raising $20 billion in capital specifically to acquire Exact Sciences.

Source

SEC EDGARFeb 26, 2026

Current report (Form 8-K)

Abbott 8-K

Filing excerpt

Abbott intends to use the net proceeds from the Notes offering, together with cash on hand and/or additional borrowings (which may include, among other things, issuances of commercial paper), to fund the consideration for the acquisition of Exact Sciences Corporation (“Exact Sciences”), to repay certain indebtedness of Exact Sciences, to pay related fees and expenses, and for general corporate purposes, which may include, without limitation, the repayment of indebtedness.

sec.gov/Archives/edgar/data/1800/000110465926020509/tm264905d7_8k.htmRead the full source

Other signals in this filing (2)

Extracted by Autobound

From the Signal API record
Signal
8-K: Acquisition announced

What this signalsIntegration work after a deal often opens needs for new systems and services.

Form
8-K
Filed
Feb 26, 2026

The full record

From the Signal API record

Numbers

Dollar figure
$20B (Aggregate principal amount of senior notes to be issued to fund the acquisition of Exact Sciences Corporation.)

Details

CIK
1800
Accession number
0001104659-26-020509
Timeframe
Current quarter
Filing year
2026
Why it matters
Integration needs coming
Signal category
Strategic

Topics and mentions

Vendors

  • Morgan Stanley & Co. LLC
  • Barclays Capital Inc.
  • BofA Securities
  • Inc.
  • J.P. Morgan Securities LLC

Vendors named

  • Morgan Stanley & Co. LLC
  • Barclays Capital Inc.
  • BofA Securities, Inc.
  • J.P. Morgan Securities LLC

Extraction

Confidence
High
Relevance
100%
Sentiment
Neutral
Detected
Mar 3, 2026
signal_type
sec-8k
signal_subtype
acquisitionAnnounced

Use this data

Get every 8-K signal for Abbott and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Abbott this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/29af9f71-0e8c-4c3c-9916-bb5c3552906b returns this record as JSON. POST /v1/companies/enrich returns every signal for abbott.com.

{
  "signal_id": "29af9f71-0e8c-4c3c-9916-bb5c3552906b",
  "signal_type": "sec-8k",
  "signal_subtype": "acquisitionAnnounced",
  "detected_at": "2026-03-03T08:24:59.481+00:00",
  "company": {
    "name": "Abbott",
    "domain": "abbott.com"
  },
  "data": {
    "detail": "Abbott is raising $20 billion in capital specifically to acquire Exact Sciences. This massive M&A event will trigger significant integration projects, technology and vendor reviews, and budget allocation for combining operations, creating major opportunities for IT, consulting, and enterprise software vendors.",
    "metrics": {
      "timeframe": "current_quarter",
      "dollar_context": "Aggregate principal amount of senior notes to be issued to fund the acquisition of Exact Sciences Corporation.",
      "dollar_millions": 20000
    },
    "summary": "Abbott raises $20B in debt to fund the acquisition of Exact Sciences Corporation.",
    "excerpts": "Abbott intends to use the net proceeds from the Notes offering, together with cash on hand and/or additional borrowings (which may include, among other things, issuances of commercial paper), to fund the consideration for the acquisition of Exact Sciences Corporation (“Exact Sciences”), to repay certain indebtedness of Exact Sciences, to pay related fees and expenses, and for general corporate purposes, which may include, without limitation, the repayment of indebtedness.",
    "relevance": 1,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1800/000110465926020509/tm264905d7_8k.htm",
    "filing_date": "2026-02-26",
    "filing_year": 2026,
    "sales_relevance": "Integration needs coming",
    "signal_category": "strategic",
    "vendors_mentioned": [
      "Morgan Stanley & Co. LLC",
      "Barclays Capital Inc.",
      "BofA Securities, Inc.",
      "J.P. Morgan Securities LLC"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.